Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stepped Care Models for PTSD in Cambodian Refugees
NCT01542372Phase 4
Key facts
- Status
- Terminated
- Start
- Apr 2012
- Primary completion
- Mar 2014
- Countries
- 1
- Sponsor
- Massachusetts General Hospital
- Drugs
- prazosin
- Conditions
- post-traumatic stress disorder (PTSD)
01
Overview
Phase 4, randomised, open-label trial of prazosin in post-traumatic stress disorder (PTSD), sponsored by Massachusetts General Hospital. Primary endpoint: PTSD Checklist at 12 weeks. Started Apr 2012; status: terminated.
02
Design
- Study design
- RandomizedOpen-label
03
Who it enrols
Cambodian genocide survivors (at least 7 years old at the time) with PTSD (PCL >= 44) who are resistant to initial SSRI/SSRN treatment.
04
Endpoints
Primary
PTSD Checklist
Secondary
Hopkins Symptom Checklist Anxiety Scale
Beyond the preview
Go deeper on NCT01542372.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01542372.